Coronavirus: India invites scepticism as it sticks by hydroxychloroquine, Covid-19 ‘treatment’ backed by Trump

The Indian government is courting controversy by continuing to give the antimalarial drug hydroxychloroquine to health care workers on the front lines of the fight against the coronavirus, despite safety concerns that have prompted the World Health Organisation to pause a large-scale trial of the drug. Scientists at the Indian Council of Medical Research (ICMR), the body leading the coronavirus battle in India, say their studies have shown definitively that the drug – also known as HCQ – helps…

Read the original article at South China Morning Post